. Author manuscript; available in PMC: 2016 May 18.

Published in final edited form as: Eur J Clin Nutr. 2015 Aug 26;70(2):269–273. doi: 10.1038/ejcn.2015.137

Table 1.

Baseline Characteristics (mean ± SD)

	Total Cohort (n=31)	Treatment Group (n=16)	Placebo group (n=15)	p-value for difference between groups
Age (years)	72 ± 6	72 ± 7	71 ± 5	0.451
Sex (% male)	45.2	43.8	46.7	0.870
Race (% Caucasian)	90.3	87.5	93.3	0.226
Weight (kg)	82.7 ± 15.6	85.4 ± 14.8	79.9 ± 16.3	0.328
BMI (kg/m²)	28.5 ± 4.3	29.4 ± 4.5	27.5 ± 4.0	0.230
Systolic blood pressure (mm Hg)	142 ± 22	147 ± 25	138 ± 16	0.257
Diastolic blood pressure (mm Hg)	81 ± 9	83 ± 10	79 ± 7	0.225
FMD (%)	8.6 ± 2.3	8.4 ± 1.8	8.9 ± 2.7	0.530
Serum hsCRP (mg/l)	2.3 ± 2.2^*	2.7 ± 2.6^**	1.9 ± 1.7^***	0.389
Serum TNF-α (pg/ml)	7.8 ± 2.2^*	7.9 ± 2.2^**	7.7 ± 2.2^***	0.101
Average energy intake (kcals)	1756 ± 396	1827 ± 408	1680 ± 381	0.308
Average protein intake (% total kcals)	17.9 ± 6.3	16.1 ± 4.6	19.8 ± 7.2	0.507

BMI = body mass index, kcals = kilocalories, FMD = flow mediated dilation

n=29,

^**

n=15,

^***

n=14